Bambusa Therapeutics Inc. Common stock (BBTX) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Bambusa Therapeutics Inc. Common stock, updated every trading day.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Price
$16.00
+6.74% today
Market cap
$767M
Overall quality
55/100
Kronos AI 30-day
—
Bambusa Therapeutics Inc. Common stock (BBTX) is a Health Care company in Biotechnology: Biological Products (No Diagnostic Substances), worth $767M. It trades at $16.00, up 6.74% today. Its overall quality score is 55 out of 100, ranked against the whole US market.
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
No analyst covers this listing yet.
Kronos AI 30-day forecast
No forecast for this listing.
Quality scores
| Profitability | 50 |
| Solvency | 70 |
| Growth | 44 |
| Overall | 55 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Halal Health Care stocks · Zakat calculator · Purification calculator
Similar companies in Biotechnology: Biological Products (No Diagnostic Substances)
For information only, not investment advice. Prices updated: 2026-11-03.